View Author
Weaver, W.D.
( W.D. Weaver)
stroke patient nonhemorrhagic stroke nonhemorrhagic study infarction hemorrhage baseline predictor trial atrial fibrillation /flutter intracranial heart event table 30- day mortality thrombolytic model mortality in-hospital intracranial hemorrhage factor therapy atrial fibrillation gusto-i thrombolysi thrombolytic therapy swets subs service /flutter circulation multivariable class history result hospital lp-pla 2 activity surgery analysis onset heart rate angina catheterization killip risk factors group killip class hospitalization in-hospital nonhemorrhagic stroke solid-timi 52 trial darapladib lp-pla investigator resource effect ischemic attack .001 subject follow-up point disease diabetes death volume อป.001 30- procedure hemorrhagic score hypertension baseline hospitalization stroke patients scale ischemic intracerebral glasgow incidence resource use cohort coll cardiol
6 Most Recent Publications
|
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
(Article)
O'Donoghue, M.L. Braunwald, E. Cicconetti, G. Lukas, M.A. Tarka, E. Cannon, C.P. White, H.D. Serruys, P.W.J.C. Steg, P.G. Hochman, J.S. Maggioni, A.P. Bode, C. Weaver, W.D. Johnson, J.L. |
2011-10-01
|
|
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study
(Article)
Tung, C.Y. White, H.D. Knight, J.D. Weaver, W.D. Mahaffey, K.W. Clapp-Channing, N. Mark, D.B. Simoons, M.L. Califf, R.M. Gore, J.M. Granger, C.B. Sloan, M.A. Topol, E.J. |
1999-01-01
|
|
Risk Factors for In-Hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis
(Article)
Mahaffey, K.W. Granger, C.B. Sloan, M.A. Thompson, T.D. Gor, J.M. Weaver, W.D. Simoons, M.L. Barbash, G.I. Topol, E.J. Califf, R.M. |
1998-01-01
|
|
Prediction of 30-Day Mortality Among Patients With Thrombolysis-Related Intracranial Hemorrhagic
(Article)
Sloan, M.A. Sila, C.A. Green, C.L. Topol, E.J. Califf, R.M. Mahaffey, K.W. Granger, C.B. Langstreth Jr, W.T. Koudstaal, P.J. White, H.D. Gore, J.M. Simoons, M.L. Weaver, W.D. |
1998-01-01
|
|
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis: Results from GUSTO-I
(Article)
Mahaffey, K.W. Califf, R.M. Topol, E.J. Granger, C.B. Sloan, M.A. Thompson, T.D. Gore, J.M. Weaver, W.D. White, H.D. Simoons, M.L. Barbash, G.I. |
1998-01-01
|
|
Selection of thrombolytic therapy for individual patients: development of a clinical model
(Article)
Califf, R.M. Woodlief, L.H. Topol, E.J. Harrell, F.E. Lee, K.L. White, H.D. Guerci, A.D. Barbash, G.I. Simes, R.J. Weaver, W.D. Simoons, M.L. |
1997-01-01
|
